Karlijn Hummelink

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Michel van den Heuvel, Daniela S Thommen, Egbert F Smit, Gerrit A Meijer, Kim Monkhorst
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. PloS one 19 (7) (2024)
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voest
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Michel van den Heuvel, Daniela S Thommen, Egbert F Smit, Gerrit A Meijer, Kim Monkhorst
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. PloS one 19 (7) (2024)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Michel van den Heuvel, Daniela S Thommen, Egbert F Smit, Gerrit A Meijer, Kim Monkhorst
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. PloS one 19 (7) (2024)
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voest
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James Robert White, Noushin Niknafs, Lamia Rhymee, Gavin Pereira, Nisha Rao, Benny Weksler, Nathan Bahary, Jillian A Phallen, Alessandro Leal, David L Bartlett, Kristen A Marrone, Jarushka Naidoo, Akul Goel, Benjamin Levy, Samuel Rosner, Christine L Hann, Susan C Scott, Josephine Feliciano, Vincent K Lam, David S Ettinger, Qing Kay Li, Peter B Illei, Kim Monkhorst, Robert B Scharpf, Julie R Brahmer, Victor E Velculescu, Blair A Jobe, Patrick M Forde, Valsamo Anagnostou
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karlijn Hummelink, Renaud Tissier, Linda J W Bosch, Oscar Krijgsman, Michel van den Heuvel, Willemijn S M E Theelen, Diane Damotte, Francois Goldwasser, Karen Leroy, Egbert F Smit, Gerrit A Meijer, Daniela S Thommen, Kim Monkhorst
A dysfunctional T cell gene signature for predicting non-response to PD-1 blockade in non-small cell lung cancer that is suitable for routine clinical diagnostics. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Ferry Lalezari, Dennis Peters, Willemijn S M E Theelen, Viktor Hendrik Koelzer, Kirsten D Mertz, Alfred Zippelius, Michel van den Heuvel, Annegien Broeks, John B A G Haanen, Ton N M Schumacher, Gerrit A Meijer, Egbert F Smit, Kim Monkhorst, Daniela S Thommen
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)